APA (7th ed.) Citation

Cullberg, M., Arfvidsson, C., Larsson, B., Malmgren, A., Mitchell, P., Wählby Hamrén, U., & Wray, H. (2018). Pharmacokinetics of the Oral Selective CXCR2 Antagonist AZD5069: A Summary of Eight Phase I Studies in Healthy Volunteers. Drugs in R&D, 18(2), 149-159. https://doi.org/10.1007/s40268-018-0236-x

Chicago Style (17th ed.) Citation

Cullberg, Marie, Cecilia Arfvidsson, Bengt Larsson, Anna Malmgren, Patrick Mitchell, Ulrika Wählby Hamrén, and Heather Wray. "Pharmacokinetics of the Oral Selective CXCR2 Antagonist AZD5069: A Summary of Eight Phase I Studies in Healthy Volunteers." Drugs in R&D 18, no. 2 (2018): 149-159. https://doi.org/10.1007/s40268-018-0236-x.

MLA (9th ed.) Citation

Cullberg, Marie, et al. "Pharmacokinetics of the Oral Selective CXCR2 Antagonist AZD5069: A Summary of Eight Phase I Studies in Healthy Volunteers." Drugs in R&D, vol. 18, no. 2, 2018, pp. 149-159, https://doi.org/10.1007/s40268-018-0236-x.